Gene · 9493
Papers1,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP36-mediated stabilization of NAT10 promotes osteosarcoma progression via ac4C-dependent KIF23 mRNA stabilization. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42826871 | PubTator, text mining | PubMed |
| Study on the potential role of KIF23 in doxorubicin-induced cardiomyopathy through multi-omics integration and AI-based screening. | Comput Biol Chem | 2026 | 42567083 | PubTator, text mining | PubMed |
| LncRNA ABCA9-AS1 as a ceRNA Promotes Gastric Cancer Progression by Sponging miR-497-5p to Regulate KIF23 Expression. | Curr Cancer Drug Targets | 2026 | 42515901 | PubTator, text mining | PubMed |
Retraction notice to "Molecular structure of polysaccharide mediated autophagy markers KIF23 and PRC1 proteins and their regulatory role in triple negative cancer through the p53 signaling pathway" [Int. J. Biol. Macromol. 291 (2025) 139155]. | Int J Biol Macromol | 2026 | 42481345 | PubTator, text mining | PubMed |
| Targeting Sirtuins in Thyroid Cancer: Mechanisms, Drug Development, and Emerging Roles in Tumor Immunity and Ferroptosis. | Cancers (Basel) | 2026 | 42449637 | PubTator, text mining | PubMed |
| The NLRP3 inflammasome in gynecological cancers: a double-edged sword shaping the immune microenvironment and immunotherapy response. | Front Immunol | 2026 | 42421965 | PubTator, text mining | PubMed |
| KIF23 in disease pathogenesis and therapeutics : from molecular mechanisms to clinical translation. | Cancer Cell Int | 2026 | 42410612 | PubTator, text mining | PubMed |
| Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study. | World J Surg Oncol | 2026 | 42365339 | PubTator, text mining | PubMed |
| The role of KIF23 in cancer: From molecular insights to therapeutic approaches. | Gene | 2026 | 42288227 | PubTator, text mining | PubMed |
| KIF11 drives ovarian cancer progression and cisplatin resistance via the Wnt/β-catenin signaling pathway. | Biochem Biophys Res Commun | 2026 | 42263603 | PubTator, text mining | PubMed |
| KIF23 in disease pathogenesis and its therapeutic and diagnostic potential. | Discov Oncol | 2026 | 42178466 | PubTator, text mining | PubMed |
| DLX6-AS1 promotes the progression of Wilms tumor by sponging miR-195-5p to upregulate KIF23 in Wilms tumor cells. | Discov Oncol | 2026 | 42154117 | PubTator, text mining | PubMed |
| Identification and validation of lactylation-related genes signature and immune infiltration landscape of rheumatoid arthritis based on machine learning. | Hereditas | 2026 | 42135859 | PubTator, text mining | PubMed |
| Integrated Multi-Omics and Machine Learning Framework Identifies Diagnostic Signatures and Druggable Targets in Breast Cancer. | Genes (Basel) | 2026 | 42074514 | PubTator, text mining | PubMed |
| KIF23 regulates cytoskeleton dynamics for cytokinesis and mitochondrial function during oocyte meiosis. | Cell Commun Signal | 2026 | 42050667 | PubTator, text mining | PubMed |
| Regulation of Citron kinase by CDK1 and Aurora B regulates midbody formation and stability. | J Cell Sci | 2026 | 42003306 | PubTator, text mining | PubMed |
| Targeting KIF23 inhibits cell proliferation and primary chemoresistance in cervical cancer by inactivating the MYH9/MCM2/PCNA pathway. | Clin Transl Med | 2026 | 41940421 | PubTator, text mining | PubMed |
| Differential MicroRNA Expression in Chronic Spontaneous Urticaria in Relation to Treatment Response. | Allergy Asthma Immunol Res | 2026 | 41914533 | PubTator, text mining | PubMed |
| CancerHubs Data Explorer: a web application for investigating mutation-enriched protein interaction hubs in human cancers. | BioData Min | 2026 | 41913220 | PubTator, text mining | PubMed |
| NCBP2 Regulates PGAM5-Mediated Mitophagy Via KIF23 Alternative Splicing To Promote Cervical Cancer ProgressionRun Title: NCBP2 Promotes Cervical Cancer Via Mitophagy. | Appl Biochem Biotechnol | 2026 | 41874817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9493/papers